|Ticker||Status||Jurisdiction||Filing Date||CP Start||CP End||CP Loss||Deadline|
|Ticker||Case Name||Status||CP Start||CP End||Deadline||Settlement Amt|
|Ticker||Name||Date||Analyst Firm||Up/Down||Target ($)||Rating Change||Rating Current|
Immunovant (NASDAQ:IMVT) reported its Q1 earnings results on Friday, August 5, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Immunovant beat estimated earnings by 12.5%, reporting an EPS of $-0.35 versus an estimate of $-0.4.
Revenue was down $0 from the same period last year.
Last quarter the company missed on EPS by $0.03 which was followed by a 4.85% drop in the share price the next day.
To track all earnings releases for Immunovant visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: IMVT